Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,227,851 | $1,065,920 | $1,313,218 | $1,997,602 |
| - Cash | $196,218 | $208,481 | $243,075 | $302,078 |
| + Debt | $19,772 | $21,711 | $23,599 | $25,404 |
| Enterprise Value | $1,051,405 | $879,150 | $1,093,742 | $1,720,928 |
| Revenue | $7,608 | $8,699 | $9,175 | $83,748 |
| % Growth | -12.5% | -5.2% | -89% | – |
| Gross Profit | $7,608 | $6,503 | $7,011 | $83,748 |
| % Margin | 100% | 74.8% | 76.4% | 100% |
| EBITDA | -$51,622 | -$50,563 | -$47,640 | $25,123 |
| % Margin | -678.5% | -581.3% | -519.2% | 30% |
| Net Income | -$53,852 | -$50,469 | -$46,878 | $29,253 |
| % Margin | -707.8% | -580.2% | -510.9% | 34.9% |
| EPS Diluted | -0.32 | -0.31 | -0.29 | 0.17 |
| % Growth | -3.2% | -6.9% | -270.6% | – |
| Operating Cash Flow | -$44,666 | -$46,012 | -$63,039 | -$43,648 |
| Capital Expenditures | -$248 | -$306 | -$165 | -$86 |
| Free Cash Flow | -$44,914 | -$46,318 | -$63,204 | -$43,734 |